Clinical studies suggest that impaired glucose tolerance (IGT) is associated with the development of neuropathy. The aim of the current study was to determine if neuropathy developed in the female Zucker Diabetic Fatty (ZDF) rat, an animal model of IGT and type 2 diabetes. The ZDF rat develops impaired glucose tolerance (IGT) when fed a control diet, and frank diabetes when fed a high fat diet. Following 10 weeks of hyperglycemia, sensory nerve action potentials (SNAP) and compound motor action potentials (CMAP) were reduced and sensory conduction velocities were slowed (distal N proximal) in the tail and hind limb in ZDF animals with IGT and frank diabetes (p b 0.01). Neuropathy was coupled with evidence of increased reactive oxygen species (ROS) and cellular injury in dorsal root ganglion (DRG) neurons from IGT animals. Our study supports the hypothesis that neuropathy develops in an animal model of IGT and is associated with evidence of oxidative injury in DRG and peripheral nerves.
Introduction
Impaired glucose tolerance (IGT) results in micro-and macrovascular complications in human patients (Singleton et al., 2003) . Clinical studies indicate that IGT is a common cause of painful sensory neuropathy (Singleton et al., 2001a (Singleton et al., , 2003 Smith et al., 2006) . The nature of neuropathy resulting from IGT is unclear and may be due to episodic increases in serum glucose, or to a generalized metabolic disturbance ("metabolic syndrome") including dyslipidemia and inflammation. While oxidative stress-induced injury in the peripheral nervous system is well characterized in rodent models of diabetes (for review see (Vincent and Feldman, 2004) ), it is unclear if similar changes occur during IGT.
The Zucker Diabetic Fatty (ZDF) rat used in this study is a model of IGT and type 2 diabetes, exhibiting insulin resistance, hyperinsulinemia, dyslipidemia (Wahle and Radcliffe, 1976; Bray, 1977; Godbole and York, 1978) and other characteristics of metabolic syndrome. Rats homozygous for a glycine 269 to proline substitution in the leptin receptor are obese, while heterozygous animals are lean, and serve as control animals in experimental studies (Clark et al., 1983) . Homozygous ZDF rats develop hyperphagia, hyperglycemia, hypercholesterolemia and hyperinsulinemia with insulin resistance at approximately 4-5 weeks of age (Clark et al., 1983; Johnson et al., 1990 ) (www.harlan.com). Male ZDF rats spontaneously progress from IGT to frank diabetes. Female ZDF rats are arrested at IGT demonstrated by abnormal glucose tolerance (Noland et al., 2007; Oltman et al., 2005 . Diabetes is induced in female ZDF rats by diet manipulation. Feeding the female the GMI 13004 diet, composed of 48% fat and 16% protein, will induce frank diabetes within 14-21 days. Female ZDF rats fed a high fat diet (ZDF-HF, diabetic) gain weight for approximately 30 days followed by weight loss compared to female ZDF rats fed a normal diet (ZDF-N, IGT); however, both animals are severely obese compared to lean control rats.
Diabetic neuropathy (DN) is reported in ZDF rats and demonstrated by decreased motor nerve conduction velocity (MNCV), decreased sensory nerve conduction velocity (SNCV) and decreased levels of calcitonin gene-related peptide (Shibata et al., 2000; Shimoshige et al., 2000; Oltman et al., 2005; Li et al., 2006) . All of these studies were performed in male diabetic ZDF
